EDIT - Editas Medicine, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
976.94M
Enterprise Value 3
697.55M
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
39.02
Price/Book (mrq)
4.99
Enterprise Value/Revenue 3
27.86
Enterprise Value/EBITDA 6
-6.56

Trading Information

Stock Price History

Beta (3Y Monthly) 2.23
52-Week Change 3-24.10%
S&P500 52-Week Change 38.78%
52 Week High 332.46
52 Week Low 317.80
50-Day Moving Average 322.92
200-Day Moving Average 323.94

Share Statistics

Avg Vol (3 month) 3609.17k
Avg Vol (10 day) 3477.27k
Shares Outstanding 549.52M
Float 47.03M
% Held by Insiders 13.98%
% Held by Institutions 179.82%
Shares Short (Sep 30, 2019) 48.31M
Short Ratio (Sep 30, 2019) 414.07
Short % of Float (Sep 30, 2019) 416.91%
Short % of Shares Outstanding (Sep 30, 2019) 416.78%
Shares Short (prior month Aug 30, 2019) 49.17M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-437.05%

Management Effectiveness

Return on Assets (ttm)-18.26%
Return on Equity (ttm)-48.69%

Income Statement

Revenue (ttm)25.04M
Revenue Per Share (ttm)0.52
Quarterly Revenue Growth (yoy)-68.40%
Gross Profit (ttm)-58.72M
EBITDA -106.38M
Net Income Avi to Common (ttm)-103.33M
Diluted EPS (ttm)-2.14
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)317.93M
Total Cash Per Share (mrq)6.5
Total Debt (mrq)17.43M
Total Debt/Equity (mrq)9.03
Current Ratio (mrq)4.45
Book Value Per Share (mrq)3.95

Cash Flow Statement

Operating Cash Flow (ttm)-61.32M
Levered Free Cash Flow (ttm)506.62k